Wells Fargo & Company Alector, Inc. Transaction History

Wells Fargo & Company

$407 Billion
Q2 2024

A detailed history of Wells Fargo & Company transactions in Alector, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 26,094 shares of ALEC stock, worth $137,515. This represents 0.0% of its overall portfolio holdings.

Number of Shares

26,094

Previous 21,879 19.27%

Holding current value

$137,515

Previous $131,000 9.92%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$4.19 - $6.23 $17,660 - $26,259	4,215 Added 19.27%	26,094 $118,000
Q1 2024 May 10, 2024	BUY	$5.69 - $8.08 $29,508 - $41,902	5,186 Added 31.07%	21,879 $131,000
Q4 2023 Feb 09, 2024	SELL	$3.77 - $8.39 $113,789 - $253,235	-30,183 Reduced 64.39%	16,693 $133,000
Q3 2023 Nov 13, 2023	SELL	$5.2 - $8.77 $43,175 - $72,817	-8,303 Reduced 15.05%	46,876 $303,000
Q2 2023 Aug 15, 2023	BUY	$5.86 - $7.93 $10,969 - $14,844	1,872 Added 3.51%	55,179 $331,000
Q1 2023 May 12, 2023	BUY	$5.85 - $9.84 $311,834 - $524,521	53,305 Added 2665250.0%	53,307 $329,000
Q4 2022 Feb 13, 2023	SELL	$6.88 - $9.55 $25,339 - $35,172	-3,683 Reduced 99.95%	2 $0
Q3 2022 Nov 14, 2022	SELL	$8.19 - $13.2 $27,854 - $44,893	-3,401 Reduced 48.0%	3,685 $35,000
Q2 2022 Aug 12, 2022	SELL	$7.65 - $14.24 $458,617 - $853,688	-59,950 Reduced 89.43%	7,086 $73,000
Q1 2022 May 16, 2022	SELL	$13.02 - $20.78 $231,677 - $369,759	-17,794 Reduced 20.98%	67,036 $955,000
Q4 2021 Feb 14, 2022	BUY	$19.35 - $25.54 $803,160 - $1.06 Million	41,507 Added 95.81%	84,830 $1.75 Million
Q3 2021 Nov 15, 2021	BUY	$21.65 - $39.49 $874,789 - $1.6 Million	40,406 Added 1385.19%	43,323 $989,000
Q2 2021 Aug 16, 2021	SELL	$15.5 - $22.48 $44,051 - $63,888	-2,842 Reduced 49.35%	2,917 $60,000
Q1 2021 May 13, 2021	SELL	$14.84 - $22.23 $1.11 Million - $1.67 Million	-74,932 Reduced 92.86%	5,759 $116,000
Q4 2020 Feb 09, 2021	BUY	$9.4 - $16.7 $572,563 - $1.02 Million	60,911 Added 307.94%	80,691 $1.22 Million
Q3 2020 Nov 05, 2020	SELL	$10.54 - $24.96 $43,730 - $103,559	-4,149 Reduced 17.34%	19,780 $209,000
Q2 2020 Aug 13, 2020	SELL	$21.87 - $33.11 $775,641 - $1.17 Million	-35,466 Reduced 59.71%	23,929 $585,000
Q1 2020 May 14, 2020	BUY	$16.25 - $35.28 $965,168 - $2.1 Million	59,395 New	59,395 $1.43 Million

Others Institutions Holding ALEC

# of Institutions

167

Shares Held

58M

Call Options Held

57K

Put Options Held

14.9K

View Full List

About Alector, Inc.

Ticker ALEC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,563,904
Market Cap $435M
Description
Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...

More about ALEC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Alector, Inc. Transaction History